title: Self-administration of bretazenil under progressive-ratio schedules: behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines.
abstract: Previous research suggests that intrinsic efficacy of benzodiazepines is an important determinant of their behavioral effects. We evaluated the reinforcing effects of the benzodiazepine partial agonist bretazenil using behavioral economic models referred to as "consumer demand" and "labor supply". Four rhesus monkeys were trained under a progressive-ratio (PR) schedule of i.v. midazolam injection. A range of doses of bretazenil (0.001-0.03 mg/kg/injection and vehicle) was evaluated for self-administration with an initial response requirement of 40 that doubled to 640; significant self-administration was maintained at doses of 0.003-0.03 mg/kg/injection. Next, a dose of bretazenil that maintained peak injections/session was made available with initial response requirements doubling from 10 to 320 (maximum possible response requirements of 160 and 5120, respectively), and increasing response requirements decreased self-administration (mean number of injections/session) of a peak dose (0.01 mg/kg/injection). Analyses based on consumer demand revealed that a measure of reinforcing strength termed "essential value", for bretazenil was similar to that previously obtained with midazolam (non-selective full agonist), but less than that observed for zolpidem (full agonist, selective for α1 subunit-containing GABA(A) receptors). According to labor supply analysis, the reinforcing effects of bretazenil were influenced by the economic concept referred to as a "price effect", similar to our previous findings with midazolam but not zolpidem. In general, behavioral economic indicators of reinforcing effectiveness did not differentiate bretazenil from a non-selective full agonist. These findings raise the possibility that degree of intrinsic efficacy of a benzodiazepine agonist may not be predictive of relative reinforcing effectiveness.
authors.affiliation: McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA.
authors.forename: Stephanie C
authors.initials: SC
authors.lastname: Licata
authors.forename: James K
authors.initials: JK
authors.lastname: Rowlett
mesh_terms: D000818:Animals; D001569:Benzodiazepines / Q000008:administration & dosage / Q000494:pharmacology*; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D008253:Macaca mulatta; D008297:Male; D018803:Models, Economic; D012055:Reinforcement Schedule; D012054:Reinforcement, Psychology; D012646:Self Administration
chemical_list: D001570:Benzodiazepinones; D001569:Benzodiazepines; C054626:bretazenil
references.citation: Biochem Soc Symp. 1993;59:121-34
references.pmid: 7910739
references.citation: Exp Clin Psychopharmacol. 2007 Aug;15(4):328-37
references.pmid: 17696679
references.citation: J Exp Anal Behav. 1988 Nov;50(3):419-40
references.pmid: 3209958
references.citation: Mol Interv. 2005 Feb;5(1):20-8
references.pmid: 15731502
references.citation: J Pharmacol Exp Ther. 1997 Oct;283(1):29-38
references.pmid: 9336305
references.citation: Psychopharmacology (Berl). 2000 Dec;153(1):139-47
references.pmid: 11255924
references.citation: Cell Tissue Res. 2006 Nov;326(2):505-16
references.pmid: 16937111
references.citation: J Exp Anal Behav. 1995 Nov;64(3):361-71
references.pmid: 8551193
references.citation: Clin Pharmacol Ther. 1994 Apr;55(4):451-63
references.pmid: 8162672
references.citation: Exp Clin Psychopharmacol. 2002 Nov;10(4):367-75
references.pmid: 12498333
references.citation: Psychopharmacology (Berl). 2000 Dec;153(1):1-16
references.pmid: 11255919
references.citation: Eur J Pharmacol. 1990 Nov 6;190(1-2):269-73
references.pmid: 1981753
references.citation: J Exp Anal Behav. 1993 Jul;60(1):129-140
references.pmid: 16812695
references.citation: Pharmacol Biochem Behav. 1999 Oct;64(2):237-43
references.pmid: 10515297
references.citation: J Pharmacol Exp Ther. 1995 Oct;275(1):183-93
references.pmid: 7562548
references.citation: Br J Pharmacol. 1989 Nov;98(3):735-40
references.pmid: 2574062
references.citation: Psychol Rev. 2008 Jan;115(1):186-98
references.pmid: 18211190
references.citation: J Exp Anal Behav. 1995 Nov;64(3):373-84
references.pmid: 8551194
references.citation: Psychopharmacology (Berl). 1993;111(4):415-22
references.pmid: 7870982
references.citation: Life Sci. 1990;47(17):1501-10
references.pmid: 2250566
references.citation: Psychopharmacology (Berl). 2000 Dec;153(1):44-56
references.pmid: 11255928
references.citation: Curr Protoc Neurosci. 2005 Aug;Chapter 9:Unit 9.21
references.pmid: 18428630
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):915-20
references.pmid: 15644443
references.citation: J Pharmacol Exp Ther. 2006 Mar;316(3):1378-85
references.pmid: 16352707
references.citation: J Pharmacol Exp Ther. 1995 Oct;275(1):405-11
references.pmid: 7562578
references.citation: Psychopharmacology (Berl). 1996 Dec;128(3):265-73
references.pmid: 8972546
references.citation: Pharmacol Biochem Behav. 1991 May;39(1):129-32
references.pmid: 1924494
references.citation: J Pharmacol Exp Ther. 1992 Jun;261(3):1113-21
references.pmid: 1318371
references.citation: Drug Alcohol Depend. 2005 Jul;79(1):53-62
references.pmid: 15943944
references.citation: Psychopharmacology (Berl). 1994 Mar;114(2):191-9
references.pmid: 7838907
references.citation: J Pharmacol Exp Ther. 1992 Jun;261(3):1106-12
references.pmid: 1318370
references.citation: Mol Pharmacol. 1993 Feb;43(2):240-4
references.pmid: 8381510
references.citation: J Pharmacol Exp Ther. 2006 Mar;316(3):1291-9
references.pmid: 16339395
references.citation: MMWR Morb Mortal Wkly Rep. 2010 Jun 18;59(23):705-9
references.pmid: 20559200
references.citation: J Pharmacol Exp Ther. 1992 Mar;260(3):1199-208
references.pmid: 1312162
references.citation: Nature. 2010 Feb 11;463(7282):769-74
references.pmid: 20148031
references.citation: Br J Pharmacol. 2006 Feb;147(3):260-8
references.pmid: 16331290
references.citation: Pharmacopsychiatry. 1988 Nov;21(6):360-2
references.pmid: 2907644
references.citation: Pharmacol Biochem Behav. 1994 Jun;48(2):397-401
references.pmid: 8090806
references.citation: Behav Pharmacol. 1999 Feb;10(1):39-50
references.pmid: 10780301
references.citation: Psychopharmacology (Berl). 2002 Oct;163(3-4):477-87
references.pmid: 12373448